about
NVP-AUY922: a small molecule HSP90 inhibitor with potent antitumor activity in preclinical breast cancer modelsE2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genesCombining hit identification strategies: fragment-based and in silico approaches to orally active 2-aminothieno[2,3-d]pyrimidine inhibitors of the Hsp90 molecular chaperoneTargeting conserved water molecules: design of 4-aryl-5-cyanopyrrolo[2,3-d]pyrimidine Hsp90 inhibitors using fragment-based screening and structure-based optimization
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Michael Rugaard Jensen
@ast
Michael Rugaard Jensen
@en
Michael Rugaard Jensen
@es
Michael Rugaard Jensen
@nl
Michael Rugaard Jensen
@sl
type
label
Michael Rugaard Jensen
@ast
Michael Rugaard Jensen
@en
Michael Rugaard Jensen
@es
Michael Rugaard Jensen
@nl
Michael Rugaard Jensen
@sl
prefLabel
Michael Rugaard Jensen
@ast
Michael Rugaard Jensen
@en
Michael Rugaard Jensen
@es
Michael Rugaard Jensen
@nl
Michael Rugaard Jensen
@sl